Cargando…

Treatment Approaches and Outcome of Patients with Neuroendocrine Neoplasia Grade 3 in German Real-World Clinical Practice

SIMPLE SUMMARY: Grade 3 neuroendocrine neoplasms (NEN G3) are a rare and heterogeneous subtype of NEN and include poorly differentiated neuroendocrine carcinomas and well-differentiated neuroendocrine tumors G3 (NET G3). Standard chemotherapy with platinum plus etoposide may not be appropriate for a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luecke, Simone, Fottner, Christian, Lahner, Harald, Jann, Henning, Zolnowski, Dominik, Quietzsch, Detlef, Grabowski, Patricia, Cremer, Birgit, Maasberg, Sebastian, Pape, Ulrich-Frank, Mueller, Hans-Helge, Gress, Thomas Matthias, Rinke, Anja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179270/ https://www.ncbi.nlm.nih.gov/pubmed/35681701 http://dx.doi.org/10.3390/cancers14112718

Ejemplares similares

Gastric neuroendocrine neoplasias: manifestations and comparative outcomes
por: Felder, S, et al.
Publicado: (2019)

Medical Treatment of Gastroenteropancreatic Neuroendocrine Tumors
por: Rinke, Anja, et al.
Publicado: (2012)

Leptomeningeal Carcinomatosis: A Clinical Dilemma in Neuroendocrine Neoplasms
por: Apostolidis, Leonidas, et al.
Publicado: (2021)

Multicenter Analysis of Presacral Neuroendocrine Neoplasms—Clinicopathological Characterization and Treatment Outcomes of a Rare Disease
por: Matrood, Sami, et al.
Publicado: (2021)

Low dose DTIC is effective and safe in pretreated patients with well differentiated neuroendocrine tumors
por: Mueller, Daniela, et al.
Publicado: (2016)

Brain metastases in patients with neuroendocrine neoplasms: risk factors and outcome
por: Krug, Sebastian, et al.
Publicado: (2019)

Quantitative Analysis of Plasma Cell-Free DNA and Its DNA Integrity and Hypomethylation Status as Biomarkers for Tumor Burden and Disease Progression in Patients with Metastatic Neuroendocrine Neoplasias
por: Mettler, Esther, et al.
Publicado: (2022)

PD-L1 – inhibitors in neuroendocrine neoplasia: Results from a real-life study
por: Özdirik, Burcin, et al.
Publicado: (2021)

Usefulness of 68-Gallium PET in Type I Gastric Neuroendocrine Neoplasia: A Case Series
por: Rinzivillo, Maria, et al.
Publicado: (2022)

Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial
por: Krug, Sebastian, et al.
Publicado: (2021)

Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Neuroendocrine Tumors in Routine Clinical Practice in Germany and Austria
por: Rinke, Anja, et al.
Publicado: (2021)

Acromegaly in a patient with a pulmonary neuroendocrine tumor: case report and review of current literature
por: Krug, Sebastian, et al.
Publicado: (2016)

Removal of multifocal neuroendocrine lung tumours with a LIMAX(® )120 Nd:YAG laser: case report
por: Kirschbaum, Andreas, et al.
Publicado: (2015)

Clinicopathological hallmarks and biomarkers of colorectal neuroendocrine neoplasms
por: Koenig, Alexander, et al.
Publicado: (2017)

Streptozocin-Based Chemotherapy in Patients with Advanced Neuroendocrine Neoplasms – Predictive and Prognostic Markers for Treatment Stratification
por: Krug, Sebastian, et al.
Publicado: (2015)

Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells
por: Krug, Sebastian, et al.
Publicado: (2019)

Preclinical Models of Neuroendocrine Neoplasia
por: Sedlack, Andrew J. H., et al.
Publicado: (2022)

Correction: Interaction between somatostatin analogues and targeted therapies in neuroendocrine tumor cells
por: Krug, Sebastian, et al.
Publicado: (2020)

CUX1—Transcriptional Master Regulator of Tumor Progression in Pancreatic Neuroendocrine Tumors
por: Krug, Sebastian, et al.
Publicado: (2020)

Vessel-Sparing Lymphadenectomy Should Be Performed in Small Intestine Neuroendocrine Neoplasms
por: Bartsch, Detlef K., et al.
Publicado: (2022)

Paraneoplastic brainstem encephalitis in a patient with exceptionally long course of a metastasized neuroendocrine rectum neoplasm
por: Boch, Michael, et al.
Publicado: (2014)

Exploring the Epigenome in Gastroenteropancreatic Neuroendocrine Neoplasias
por: Sharma, Rohini, et al.
Publicado: (2021)

Landscape and Future Perspectives of Immunotherapy in Neuroendocrine Neoplasia
por: Maggio, Ilaria, et al.
Publicado: (2020)

Frequency and Prognostic Significance of Intertumoural Heterogeneity in Multifocal Jejunoileal Neuroendocrine Tumours
por: Jesinghaus, Moritz, et al.
Publicado: (2022)

The Patient’s Point of View: COVID-19 and Neuroendocrine Tumor Disease
por: Krug, Sebastian, et al.
Publicado: (2022)

The Role of Alternative Lymph Node Classification Systems in Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NEN): Superiority of a LODDS Scheme Over N Category in Pancreatic NEN (pNEN)
por: Krieg, Sarah, et al.
Publicado: (2023)

Complications of surgery for gastro-entero-pancreatic neuroendocrine neoplasias
por: Albers, Max B., et al.
Publicado: (2020)

High expression of insulinoma‐associated protein 1 (INSM1) distinguishes colorectal mixed and pure neuroendocrine carcinomas from conventional adenocarcinomas with diffuse expression of synaptophysin
por: Litmeyer, Anne‐Sophie, et al.
Publicado: (2023)

Gastroenteropancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1
por: Tonelli, Francesco, et al.
Publicado: (2012)

Exploration of Novel Prognostic Markers in Grade 3 Neuroendocrine Neoplasia
por: Abdelmalak, Rebecca, et al.
Publicado: (2021)

Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1
por: Marini, Francesca, et al.
Publicado: (2021)

Knife-assisted resection (KAR) for small rectal neuroendocrine neoplasia
por: Lisotti, Andrea, et al.
Publicado: (2020)

Pediatric Neuroendocrine Neoplasia of the Parathyroid Glands: Delving into Primary Hyperparathyroidism
por: Carsote, Mara, et al.
Publicado: (2023)

Epithelial-Mesenchymal Transition Is a Critical Step in Tumorgenesis of Pancreatic Neuroendocrine Tumors
por: Fendrich, Volker, et al.
Publicado: (2012)

Molecular identification of bronchopulmonary neuroendocrine tumours and neuroendocrine genotype in lung neoplasia using the NETest liquid biopsy
por: Filosso, Pier Luigi, et al.
Publicado: (2020)

Metastatic neuroendocrine neoplasia treatments in patients over 70 years of age
por: Bongiovanni, Alberto, et al.
Publicado: (2018)

Therapy of Patients with Neuroendocrine Neoplasia—Evidence-Based Approaches and New Horizons
por: Bundschuh, Ralph A., et al.
Publicado: (2019)

Anxiety, Depression and Quality of Life in Patients with Neuroendocrine Neoplasia After Surgery
por: Begum, Nehara, et al.
Publicado: (2022)

Thymic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1
por: Yliaska, Iina, et al.
Publicado: (2022)

Utility of histopathological revision in the management of gastro-entero-pancreatic neuroendocrine neoplasia
por: Marasco, Matteo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cmrjmpr3fk93qt4feu722qhnmp